SI2291380T1 - Predzdravila nalmefena - Google Patents

Predzdravila nalmefena

Info

Publication number
SI2291380T1
SI2291380T1 SI200930109T SI200930109T SI2291380T1 SI 2291380 T1 SI2291380 T1 SI 2291380T1 SI 200930109 T SI200930109 T SI 200930109T SI 200930109 T SI200930109 T SI 200930109T SI 2291380 T1 SI2291380 T1 SI 2291380T1
Authority
SI
Slovenia
Prior art keywords
compounds
nalmefene
disorders
alcohol
prodrugs
Prior art date
Application number
SI200930109T
Other languages
English (en)
Inventor
Michel Joseph Maurice Andre Guillaume
Tim Gaekens
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SI2291380T1 publication Critical patent/SI2291380T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200930109T 2008-04-24 2009-04-23 Predzdravila nalmefena SI2291380T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08155094 2008-04-24
PCT/EP2009/054882 WO2009130272A1 (en) 2008-04-24 2009-04-23 Nalmefene prodrugs
EP09733923A EP2291380B1 (en) 2008-04-24 2009-04-23 Nalmefene prodrugs

Publications (1)

Publication Number Publication Date
SI2291380T1 true SI2291380T1 (sl) 2012-01-31

Family

ID=39816976

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200930109T SI2291380T1 (sl) 2008-04-24 2009-04-23 Predzdravila nalmefena

Country Status (19)

Country Link
US (1) US8440686B2 (sl)
EP (1) EP2291380B1 (sl)
JP (1) JP6009764B2 (sl)
KR (1) KR101598137B1 (sl)
CN (1) CN102066381A (sl)
AT (1) ATE523512T1 (sl)
AU (1) AU2009239929B2 (sl)
CA (1) CA2722246C (sl)
CY (1) CY1112295T1 (sl)
DK (1) DK2291380T3 (sl)
ES (1) ES2373364T3 (sl)
HR (1) HRP20110824T1 (sl)
ME (1) ME01319B (sl)
PL (1) PL2291380T3 (sl)
PT (1) PT2291380E (sl)
RS (1) RS52041B (sl)
RU (1) RU2495042C2 (sl)
SI (1) SI2291380T1 (sl)
WO (1) WO2009130272A1 (sl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3703694A4 (en) * 2017-11-03 2021-08-18 Nirsum Laboratories, Inc. MEDICINES ANTAGONISTS OF OPIOID RECEPTORS
TW202015684A (zh) * 2018-06-21 2020-05-01 景凱生物科技股份有限公司 那曲酮、納美芬及其衍生物之前藥
WO2020223894A1 (en) * 2019-05-07 2020-11-12 Nirsum Laboratories, Inc. Opioid receptor antagonist prodrugs

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US5086058A (en) * 1990-06-04 1992-02-04 Alko Ltd. Method for treating alcoholism with nalmefene
JPH06271578A (ja) * 1993-03-15 1994-09-27 Natl Sci Council 鎮痛剤ナルブフィン前薬の誘導体
DE69427551T2 (de) 1993-03-15 2002-05-16 National Science Council, Taipeh/T'ai-Pei Nalbuphinester und diese enthaltende Arzneimittel mit verzögerter Wirkstoffabgabe
US5869669A (en) * 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
JP2005508888A (ja) * 2001-08-14 2005-04-07 バイオティ セラピーズ コーポレイション アルコール依存症またはアルコール中毒を治療する方法
US20040033253A1 (en) 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
US7759358B2 (en) * 2003-07-23 2010-07-20 Crooks Peter A Oral bioavailable prodrugs
US20110105381A2 (en) * 2007-02-16 2011-05-05 Pharmacofore, Inc. Prodrugs of Peripheral Phenolic Opioid Antagonists
SI2307420T1 (sl) * 2008-04-24 2012-05-31 Janssen Pharmaceutica Nv Predzdravila nalmefen di estra

Also Published As

Publication number Publication date
JP6009764B2 (ja) 2016-10-19
CY1112295T1 (el) 2015-12-09
EP2291380A1 (en) 2011-03-09
PT2291380E (pt) 2011-12-22
HRP20110824T1 (hr) 2012-01-31
WO2009130272A1 (en) 2009-10-29
DK2291380T3 (da) 2011-12-05
ME01319B (me) 2013-12-20
EP2291380B1 (en) 2011-09-07
ES2373364T3 (es) 2012-02-02
PL2291380T3 (pl) 2012-02-29
JP2011518805A (ja) 2011-06-30
KR20110004877A (ko) 2011-01-14
US8440686B2 (en) 2013-05-14
AU2009239929B2 (en) 2014-02-13
AU2009239929A1 (en) 2009-10-29
KR101598137B1 (ko) 2016-02-29
RU2010147833A (ru) 2012-05-27
ATE523512T1 (de) 2011-09-15
US20110034502A1 (en) 2011-02-10
RU2495042C2 (ru) 2013-10-10
CN102066381A (zh) 2011-05-18
CA2722246A1 (en) 2009-10-29
CA2722246C (en) 2016-06-21
RS52041B (en) 2012-04-30

Similar Documents

Publication Publication Date Title
SI2307420T1 (sl) Predzdravila nalmefen di estra
CA2871471C (en) Dna-pk inhibitors
MY191669A (en) Pyrazolyl quinoxaline kinase inihibitors
SG179120A1 (en) Novel compounds
WO2011082273A3 (en) Substituted pyrrolo-aminopyrimidine compounds
WO2011082270A3 (en) Substituted imidazopyridinyl-aminopyridine compounds
WO2010147898A3 (en) Small molecule inhibitors of spleen tyrosine kinase (syk)
MX2013001970A (es) Compuestos de pirrolopirimidina y usos de los mismos.
WO2011082267A8 (en) Substituted triazolo-pyrazine compounds
WO2011082266A3 (en) Substituted heterocyclic compounds
IN2012DN02081A (sl)
MX349004B (es) Nuevos compuestos.
NZ590650A (en) Buprenorphine analogs
MX337611B (es) Compuestos para el tratamiento de la adiccion.
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
MX2014013090A (es) Derivados de pirrolotriazinona.
MX2009005938A (es) 6-oxo-1,6-dihidro-pirimidin-2-ilos en el tratamiento de enfermedades proliferativas.
WO2011082268A3 (en) Substituted naphthalenyl-pyrimidine compounds
WO2010027424A3 (en) 9-substituted phenanthrene based tylophorine derivatives
SI2291380T1 (sl) Predzdravila nalmefena
WO2010027458A3 (en) Pdk inhibitor compounds and methods of use thereof
UA103197C2 (uk) Застосування ніфуртимоксу для лікування хвороб, спричинених трихомонадами
WO2009126335A3 (en) Ant2 inhibitor compounds and methods of use thereof
WO2009151495A3 (en) Oxazole compounds, compositions and methods of use
WO2011082271A3 (en) Substituted triazolo-pyrimidine compounds